Regarding the treatment of HNF1B/MODY, patients present hepatic insulin resistance to some extent [107], and thus the treatment with oral hypoglycemic agents such as sulfonylureas may not be satisfactory, and early insulin therapy may be requested [108]. Here, INS is linked to Insulin resistance.